Investment Thesis
RxSight exhibits fundamental operational distress despite fortress balance sheet. The company is unprofitable with negative operating income of -$17.8M, declining revenue (-3.9% YoY), and burning cash operationally (-$10.9M annually). While the 76.1% gross margin demonstrates product viability, excessive operating expenses erode all margin, and the current cash position ($17.6M) provides limited runway at present burn rates.
Strengths
- Fortress balance sheet with zero long-term debt and $304M in total assets
- Exceptional gross margin of 76.1% indicates strong product pricing power and market demand
- Excellent short-term liquidity with 10.2x current ratio and 8.93x quick ratio
Risks
- Negative net income of -$15.9M and net margin of -51.4% with no clear path to profitability
- Declining revenue (-3.9% YoY) combined with negative operating cash flow (-$10.9M) indicates deteriorating business fundamentals
- Operating expenses unsustainable relative to revenue base; cash runway of ~18-20 months at current burn rate given limited relative cash position
- Negative ROE and ROA suggest inefficient capital deployment despite substantial asset base
Key Metrics to Watch
- Quarterly revenue trend reversal and YoY growth trajectory
- Operating margin improvement and path to operating profitability
- Operating cash flow conversion and monthly cash burn rate sustainability
Financial Metrics
Revenue
30.9M
Net Income
-15.9M
EPS (Diluted)
$-0.38
Free Cash Flow
-11.7M
Total Assets
304.0M
Cash
17.6M
Profitability Ratios
Gross Margin
76.1%
Operating Margin
-57.7%
Net Margin
-51.4%
ROE
-5.9%
ROA
-5.2%
FCF Margin
-37.7%
Balance Sheet & Liquidity
Current Ratio
10.20x
Quick Ratio
8.93x
Debt/Equity
0.00x
Debt/Assets
12.1%
Interest Coverage
-5,943.00x
Long-term Debt
0.0
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-08T12:15:27.467673 |
Data as of: 2026-03-31 |
Powered by Claude AI